Robert Kim
Overview
Robert Kim received $4M in total compensation, including $456K in salary, at 4D Molecular Therapeutics in 2023.
Source: SEC filing on April 10, 2024.
Related executives
We found six more executives who work or worked at 4D Molecular Therapeutics.
David Kirn
4D Molecular Therapeutics
Chief Executive Officer
Fariborz Kamal
4D Molecular Therapeutics
Chief Operating Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
Theresa Janke
4D Molecular Therapeutics
Chief of Staff
Robert Fishman
4D Molecular Therapeutics